Biotech Stocks Higher (ASTM, DSCO, SVNT)

Aastrom Biosciences, Inc. (NASDAQ:ASTM) soared 13.82% to $2.47 on about 2.85 million shares. Aastrom Biosciences, Inc. is in the development-stage. Aastrom is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues.

The 52-week range of the stock is $1.32-$4.45. In the past one month of trading sessions, the stock went up more than 21%.

Discovery Laboratories, Inc. (NASDAQ:DSCO) added 3.65% to $0.207 on over 1.51 million shares.

Discovery Laboratories, Inc. is a biotechnology company developing surfactant therapies to treat respiratory disorders and diseases. The Company’s KL4 technology produces a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to pulmonary surfactant, a substance produced naturally in the lung and essential for survival and normal respiratory function.

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) is 1.22% higher at $12.49. Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA (pegloticase), or KRYSTEXXA, for the treatment of chronic gout in patients refractory to conventional therapy.

The stock opened at 412.25 and is trading within the range of $12.12-$12.88. At current market price, the market capitalization of the company stands at $877.52 million.

Article published by Wall Street Grand. Visit the Wall Street Grand Club today.